I share your optimism on the vaccine front. One of the challenges that needs to be solved right now is the logistics of getting the vaccines to the providers to vaccinate people and storing it. A clip from the article attached shows some of the challenges around temperature. I imagine coordinating this and ensuring there’s enough freezer capacity to deliver the vaccine to places where it can be distributed is a challenge and those locations that receive the vaccine have t9 have the capacity to store it. Lots of logistics beyond just getting a vaccine that works. I have confidence corporate America will figure this out between big pharma and shipping and healthcare companies (UPS, FedEx, CVS, etc). I have less faith in the government helping out other than writing some checks.
DEEP FREEZE
Companies and health officials also are working on ways to distribute COVID-19 vaccines, some of which must be shipped and stored at extremely cold temperatures.
Dr. Nancy Messonnier, director of the CDC's National Center for Immunization and Respiratory Diseases, questioned Pfizer's plans after the company said its vaccine must be stored at ultra-low temperatures for up to 6 months or in specially designed shipping containers for up to 10 days.
Once removed from the containers, the vaccine can be kept for up to a day at a temperatures between 2 and 8 degrees Celsius (36-46°F) - roughly the temperature of a normal refrigerator - or 2 hours at room temperature.
The complexities of this plan for vaccine storage and handling will have major impact in our ability to efficiently deliver the vaccine," Messonnier said.
Pfizer told the CDC panel it is working on making the vaccine stable at higher temperatures. Pfizer shares were down about 1.5%.
Moderna's vaccine has to be kept at minus 20 degrees Celsius for shipping and longer-term storage of up to six months, but it can be kept at regular refrigeration temperatures for up to 10 days. The vaccine will be distributed in 10-dose vials with no preservatives, the company said.
Moderna is also working to make the vaccine stable at higher temperatures, Miller said.